Non-constant tumour blood flow: Implications for therapy

Acta Oncologica

Volumn 40, Issue 7, 2001, Pages 862-869

  Durand, Ralph E ^a   Aquino Parsons, Christina ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; BLOOD; CHEMOTHERAPY; GRAFTS; RADIOTHERAPY;

PERFUSION-LIMITED HYPOXIA;

TUMORS;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; QUANTITATIVE ASSAY; TUMOR BIOPSY; TUMOR BLOOD FLOW; TUMOR GROWTH; XENOGRAFT;

ADENOCARCINOMA; ANIMALS; ANOXIA; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; COLONIC NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MICE; MICE, NUDE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; RADIOTHERAPY; REGIONAL BLOOD FLOW; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; UTERINE CERVICAL NEOPLASMS;

EID: 0035682917     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860152703508     Document Type: Article

References (36)

1. Inducible repair and the two forms of tumour hypoxia - Time for a paradigm shift
2. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
3. The histological structure of some human lung cancers and the possible implications for radiotherapy
4. Hypoxia in tumors: A paradigm for the approach to biochemical and physiologic heterogeneity
5. Modification of normal tissue response to radiotherapy and chemotherapy
6. Tumour hypoxia: The picture has changed in the 1990s
7. Delivery of novel therapeutic agents in tumors: Physiological barriers and strategies
8. Cell selection from a murine tumour using the fluorescent probe Hoechst 33342
9. The use of fluorescent probes to identify regions of transient perfusion in murine tumors
10. Contribution of transient blood flow to tumour hypoxia in mice
11. Validation of the fluorescent dye Hoechst 33342 as a vascular space marker in tumours
12. Tumor radiosensitization by nicotinamide: A result of improved perfusion and oxygenation
13. Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts
14. Microregional fluctuations in perfusion within human tumours detected using laser Doppler flowmetry
15. In vivo labelling with halogenated pyrimidines of squamous cell carcinomas and adjacent non-involved mucosa of head and neck region
16. Tumour blood flow influences combined radiation and doxorubicin treatments
17. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors
18. Development of bioreductive markers for tumour hypoxia
19. Identification of nonproliferating but viable hypoxic tumor cells in vivo
20. Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology
21. Characterization of the WIDR: A human colon carcinoma cell line
22. Cell kinetics and repopulation parameters of irradiated xenograft tumours in SCID mice: Comparison of two dose-fractionation regimens
23. Repopulation characteristics and cell kinetic parameters resulting from multi-fraction irradiation of xenograft tumors in SCID mice
24. pot in heterogeneous systems: A new approach illustrated with multicell spheroids
25. Pharmacokinetics, binding and distribution of Hoechst 33342 in spheroids and murine tumours
26. Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice
27. The lifetime of hypoxic human tumor cells
28. pot!
29. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: A multicenter analysis
30. The hazard of accelerated tumor clonogen repopulation during radiotherapy
31. The phantom of tumor treatment - Continually rapid proliferation unmasked
32. Comparative analysis of different approaches to investigate cell kinetics
33. Proliferation assays in prognosis of cancer
34. Cell proliferation measurements by bromodeoxyuridine or thymidine incorporation: Clinical correlates
35. Carbogen inhalation in cervical cancer: Assessment of oxygenation change
36. The comet assay in clinical practice